Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on whether ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

NASM's Understanding Weight Loss Medications offers fitness and wellness professionals comprehensive, evidence-based research, along with exercise, nutrition, and behavioral strategies to support ...

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, ...

What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...